Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

108results about How to "Solve the problem of insoluble in water" patented technology

Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof

The invention discloses a prodrug system prepared by connecting a series of oligopolymers synthesized by a group protection and deprotection method and polyethyleneglycol to be used as a drug carrier, belonging to the technical field of chemical drugs. Laden drugs are water-insoluble anti-tumor drugs such as taxol, or other cancer therapy drugs such as doxorubicine and camptothecin. A research discovers that drug compositions prepared by the method greatly improve the hydrophobic nature of the anti-tumor drugs and can accurately control the gather time of the oligopolymers on focus parts and the hydrolyzation rupture time of ester bonds by accurately controlling the lengths of segmers of the oligopolymers so as to control the drug release time so that drugs are stably released, thereby the method prevents burst release causing toxic side effect on normal cells, reduces the drug dosage to enhance the curative effect and sufficiently plays a sustained and controlled release role; and in addition, the structure of the oligopolymers is accurate, and the molecular weight of synthesized amphipathic block polymers which are uniformly distributed is accurate, thereby the method can ensure synthesized drug ingredients to be definite and stable and the pharmacokinetics and the treatment effect (activity and toxicity) of the synthesized drugs to have good reproduction quality and be accurately defined.
Owner:XIANGTAN UNIV

Immunochemotherapy pharmaceutical composition and preparation method therefor

The invention discloses an immunochemotherapy pharmaceutical composition. The immunochemotherapy pharmaceutical composition is formed by mixing a first mixture with a second mixture; the first mixturecontains immunoadjuvant imiquimod R837; the second mixture contains chemotherapeutic drug oxaliplatin which can cause immunogenicity death, and further contains poloxamer 188 and sodium alginate (ALG); the first mixture is an imiquimod emulsion obtained by mixing the imiquimod R837 with the poloxamer 188; imiquimod particles each have a particle size of 0.5-3 mum; the imiquimod emulsion undergoesmoist heat sterilization; and the second mixture is a mixture prepared in a manner that the sodium alginate (ALG) and the oxaliplatin are stirred and mixed with water, and filtration sterilization isperformed with a micrometer filter membrane. The new anti-cancer pharmaceutical composition can exert the synergistic anticancer effect, reduces the side effect, the cancer metastasis probability andthe cancer recurrence probability, and can inhibit the growth of a distant metastatic tumor and reduce the tumor recurrence probability through the immunoreaction while effectively killing a tumor insitu; and meanwhile, the production process is relatively optimal, and the product stability is high.
Owner:SUZHOU INNOVATIVE BIOMATERIALS & PHARM CO LTD

Preparation method of chicken infectious bronchitis virus HA antigen

InactiveCN102391366ASolve the problem of reducing potencySolve inaccurateDepsipeptidesWater bathsAntigen
The invention discloses a preparation method of a chicken infectious bronchitis virus HA antigen. In the preparation method, an A-type clostridium perfringen is adopted to treat a virus solution, so that the problem that in the conventional method, the preparation cost of the antigen is high is solved; an adopted stabilizing agent is N-2-hydroxypropyl trimethyl ammonia chloride chitosan and is water-soluble, so that the problem that the conventional stabilizing agent chitosan is water-insoluble is solved; an adopted deactivating method is deactivation for 30 minutes in water bath of 56 DEG C, so that the problem that the titer is reduced after a deactivating agent is added is solved; an adopted chicken red blood cell suspension has the concentration of 0.5 percent, so that the judgment result is more stable and the problem that the judgment result is not accurate is solved; due to adoption of dialysis bag for concentration, the problem that the titer of the antigen is low is solved; therefore, the invention provides the preparation method of the chicken infectious bronchitis virus HA antigen, which is low in cost, high in titer, and high in stability and safety, and the prepared IBV (infectious bronchitis virus) HA antigen can be successfully applied to detection on the titer of a serum HI antibody after chickens are immunized by an IBV vaccine.
Owner:哈药集团生物疫苗有限公司

Preparation method of rose geranium essential oil microcapsules with good oxidation resistance and antibacterial properties

The invention discloses a preparation method of rose geranium essential oil microcapsules with good oxidation resistance and antibacterial properties, and belongs to the technical field of food processing. The preparation method comprises the following steps of using protein and polysaccharide as wall materials, and using rose geranium essential oil as a core material; performing high-speed shearing and high-pressure homogenizing so that the wall materials and the core material are jointly emulsified, adjusting pH, adding a curing agent, and performing a complex coacervation method so as to obtain turbid liquid of the rose geranium essential oil microcapsules; and then performing freeze drying so as to obtain the rose geranium essential oil microcapsules. The microcapsules prepared by the preparation method disclosed by the invention can load and protect the rose geranium essential oil, the stability of the rose geranium essential oil is improved, the oxidation resistance of the rose geranium essential oil is well exerted, and the rose geranium essential oil microcapsules have the effect of restraining bacteria; and besides, the preparation method disclosed by the invention is simple in technology, mild in conditions, low in cost, safe and harmless, and is suitable for various fields of foods, health-care products, cosmetics and the like.
Owner:NORTHWEST A & F UNIV

Yiqing granule preparing method

The invention discloses a Yiqing granule preparing method. The method comprises the following steps: respectively extracting dry extract powder from rhizoma coptidis, rheum officinale and radix scutellaria; adding a pharmaceutically-acceptable auxiliary material in the dry extract powder of rhizoma coptidis, evenly mixing, and adding an ethanol-water solution or water so as to prepare rhizoma coptidis granules; adding a pharmaceutically-acceptable auxiliary material in the dry extract powder of rheum officinale, evenly mixing, and adding a sodium hydroxide water solution or an ethanol-water solution containing sodium hydroxide so as to prepare rheum officinale granules; adding a pharmaceutically-acceptable auxiliary material in the dry extract powder of radix scutellariae, evenly mixing, and adding a sodium hydroxide water solution or an ethanol-water solution containing sodium hydroxide so as to prepare radix scutellaria granules; finally mixing rhizoma coptidis granules, rheum officinale granules and radix scutellaria granules to obtain mixed granules, and sub-packaging the mixed granules in bags, thereby obtaining Yiqing granules. The Yiqing granules prepared by virtue of the method have qualified dissolubility and a strong curative effect and are safe and effective to take; besides, the technology is simple; the application prospect is broad.
Owner:SICHUAN FENGCHUN PHARMA

Preparation method of synergistic tylosin tartrate soluble powder compound medicine

The invention aims at providing a preparation method of a synergistic tylosin tartrate soluble powder compound medicine. The synergistic tylosin tartrate soluble powder compound medicine has a rapid and definite curative effect on respiratory system infections and complications of livestock and poultry. The preparation method comprises the following steps of: mixing 0.2 part of trimethoprim and 0.2 part of cosolvent, then crushing, and sieving by using a 120 meshes sieve or a finer sieve; and then uniformly mixing with 1 part of tylosin tartrate, 1 part of kanamycin sulfate and 0.05-0.1 part of pain alleviant by an equivalently successive increase method, thus obtaining the synergistic tylosin tartrate soluble powder compound medicine. The cosolvent is citric acid or succinic acid or the mixture of citric acid and succinic acid and the pain alleviant is procaine hydrochloride or lidocaine hydrochloride or the mixture of procaine hydrochloride and lidocaine hydrochloride. The animal synergistic tylosin tartrate soluble powder compound medicine for injection contains three medical components which are tylosin tartrate, kanamycin sulfate and trimethoprim, can be used for solving the problems that the secondary infection cannot be controlled very well during the treatment of mycoplasma infection due to the narrow antibacterial spectrum of the tylosin tartrate, and the trimethoprim is insoluble in water, has a synergistic effect on tylosin tartrate and kanamycin sulfate and has an obvious medicine curative effect.
Owner:四川联美生物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products